---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-097705"
form_type: "8-K"
ticker: "APM"
cik: "0001734005"
company_name: "Aptorum Group Ltd"
filed_at: "2026-09-04T20:31:51+00:00"
generated_at: "2026-09-04T20:33:16.834982+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Niki BioSolutions names Ian Huen CEO/Chairman and Alidad Mireskandari President/COO

## Summary
- Ian Huen appointed CEO and Chairman effective Aug 1, 2026; 6-month initial term, HKD 210,000/month (~USD 26,800).
- Alidad Mireskandari named President and COO; annual base salary $320,000, rising to $350,000 if $5M capital raised.
- Mireskandari receives 20,000 RSUs vesting at merger close and options for 800,000 shares under 2026 Equity Incentive Plan.
- Appointments follow July 22, 2026 merger where Niki acquired DiamiR Biosciences; Mireskandari was DiamiR's prior CEO.
- Mireskandari severance: 6 months' base salary, increasing to 12 months as of Jan 1, 2027; 2-year initial term.

## SEC filing metadata
- accession: 0001213900-26-097705
- form_type: 8-K
- ticker: APM
- cik: 0001734005
- company_name: Aptorum Group Ltd
- filed_at: 2026-09-04T20:31:51+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1734005/000121390026097705/0001213900-26-097705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1734005/000121390026097705/ea0304290-8k_nikibio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-097705
- JSON: https://secwatch.observer/filing/0001213900-26-097705.json
- Plain text: https://secwatch.observer/filing/0001213900-26-097705.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.